References
Chobanian et al (2003) Seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension 42(6):1206–1252
Krum H, Schlaich M, Whitbourn R et al (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373(9671):1275–1281
Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376(9756):1903–1909
Symplicity HTN-1 Investigators (2011) Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 57(5):911–917
Conflict of interest
Jonathan Moss reports Grants from Medtronic, outside the submitted work. Dierk Vorwerk, Anna Maria Belli, Jan Peregrin, Michael Lee and Jim Reekers has nothing to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moss, J., Vorwerk, D., Belli, A.M. et al. Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Position Statement on Renal Denervation for Resistant Hypertension. Cardiovasc Intervent Radiol 37, 11–12 (2014). https://doi.org/10.1007/s00270-013-0767-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-013-0767-z